Draxis Health Inc /CN/ - Report of Foreign Issuer (6-K)
28 Maggio 2008 - 9:00PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15-d-16 of
The Securities Exchange Act of 1934
For May 28, 2008
Commission File Number 000-17434
DRAXIS
HEALTH INC.
(Translation of registrants name into English)
Suite 4700, TD Bank Tower
Toronto Dominion Centre
Toronto, Ontario M5K 1E6
CANADA
(Address of principal offices)
Registrant files annual reports under cover of Form 20-F
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
DRAXIS HEALTH INC.
|
|
|
|
|
|
By:/s/ Alida Gualtieri
|
General Counsel & Secretary
|
Dated:
May 28, 2008
2
Grafico Azioni Draxis Health (MM) (NASDAQ:DRAX)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Draxis Health (MM) (NASDAQ:DRAX)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Draxis Health (MM) (NASDAQ): 0 articoli recenti
Più Draxis Health Inc /CN/ Articoli Notizie